medigraphic.com
SPANISH

Revista Médica de Costa Rica y Centroamérica

Colegio de Medicos y Cirujanos República de Costa Rica
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2014, Number 611

<< Back Next >>

Rev Med Cos Cen 2014; 71 (611)

Eyaculación Precoz (Nuevas Terapias)

Agüero HJ
Full text How to cite this article

Language: Spanish
References: 14
Page: 463-469
PDF size: 216.37 Kb.


Key words:

No keywords

ABSTRACT

Premature ejaculation is for the most common sexual dysfunction, with an incidence of approximately 30 %. This is defined as persistent or recurrent ejaculation with minimal sexual stimulation before, during or after penetration and before the person wishes it. Several theories attempt to explain its pathophysiology, however are both the psychological and neural factors the responsible of this problem. Clinical manifestations are the cornerstone of diagnosis, and the environment in which they develop symptoms should never be ignored, because often explains this problem. Multiple therapies have been studied in the management of this condition, some as SSRIs have greater support for studies that clearly demonstrate its effectiveness. Moreover recently develop new therapies, such is the case, tramadol, opioid analgesic that has demonstrated efficacy in delaying ejaculation time. With clear advantages over other drugs used for the same purpose.


REFERENCES

  1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4 th edition, DC: American Psychiatric Association; 2000.

  2. Busato W, Galindo CC. Topical anaesthetic use for treating premature ejaculation: a doubleblind, randomized, placebocontrolled study. BJU Int 2004 May; 93 (7):1018-21.

  3. Cardona, W. Definición actual y tratamiento de la eyaculación precoz. Arch. Esp. Urol. Andrología. 2010; 63 (1): 53-55

  4. Campbell-Walsh. Urología. Eyaculación Precoz. Editorial Médica Panamericana, 9° edición, 2008. Pp 784

  5. Chen J, Keren-Paz G, Bar- Yosef Y, Matzkin H. The role of phosphodiesterase type 5 inhibitors in the management of premature ejaculation: a critical analysis of basis science and clinical data. Eur Urol 2007 Nov; 52(5): 1331-9.

  6. Metz ME, Pryor JL, Nesvacil LJ, Abuzzahab F Sr, Kosnar J. Premature ejaculation: a psychophysiological review. J Sex Marital Ther 1997 Spring; 23 (1): 3-23 http://www. ncbi.nlm.nih.gov/pubmed/9094032.

  7. Montague DK, Jarow J, Broderick GA, Dmochowski RR, Heaton JP, Lue TF, et al. AUA guideline on the pharmacologic management of premature ejaculation. J Urol, 2004; 172: 290

  8. Rowland DL, Slob AK. Premature ejaculation: psychophysiological considerations in theory, research, and treatment. Annu Rev Sex Res 1997; 8:224.

  9. Safarinejad, M.R., Hosseini, S.Y. Safety and efficacy of tramadol in the treatment of premature ejaculation: a double-blind, placebo-controlled, fixed-dose, randomized study. Journal of clinical psychopharmacology. (2006).

  10. Salem. E, Steven. K, Wilson. MD, Nabil. K, Bissada, MD, Johan. R, Delk. II, Wayne. J, Hellstrom, MD, Cleves. M. Tramadol HCL has Promise in On-Demand use to Treat Premature Ejaculation. J Sex Med 2008; 5: 188-193. International Society FOR Sexual Medicina.

  11. Waldinger, M. MD, PhD. Eyaculación precoz: estado de la cuestión. Urol Clin N Am 34 (2007) 591-599

  12. Waldinger MD, Zwinderman AH, Schweitzer DH, Olivier B: Relevance of methodological design for the interpretation of efficacy of drug treatment of premature ejaculation: A systematic review and meta-analysis. Int J Impor Res 2004b; 16: 369-381.

  13. Wespes, E. Amar, I. Eardly, F. Giuliano, D. Hatzichristou, K. Hatzichristou, F. Montorsi, Y. Guía clínica sobre la disfunción sexual masculine: disfunción eréctil y eyaculación precoz. European Association of Urology. 2010. Pp 881-900.

  14. World Health Organization. The ICD-10 classification of mental and behavioural disorders: diagnostic criteria for research. Genova (IL): World Health Organization; 1993.




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Rev Med Cos Cen. 2014;71